Burlington, MA, June 9, 2021 – MilliporeSigma will hold a collaborative seminar with the Korea Federation of Women’s Science and Technology Associations (KOFWST) about ways to ensure a safe and healthy laboratory environment for pregnant scientists.
“MilliporeSigma is committed to supporting KOFWST in creating safe lab environments,” said Ji-Young Chung, head of Sales, Research Solutions, MilliporeSigma Life Science, Korea. “We hope that this seminar, tailored for scientists who are expecting, will raise the importance of the precautions necessary for handling chemicals in the lab during pregnancy.”
The speakers include numerous experts on the topic:
“KOFWST has published a guidebook called Safe Lab Life for the Scientists Who are Expecting a Baby, in March 2021 to provide educational information on chemicals used in lab that pregnant scientists should be mindful of,” said Heesun Chung, chairman of KOFWST. “This is a timely seminar to promote this important topic of building a safer, conducive and healthy lab environment for our researchers.”
In October 2020, Research and Applied Solutions of MilliporeSigma Life Science Korea signed a Memorandum of Understanding (MoU) with KOFWST to address strengthening the topic of safety in the field of science and technology. In the inaugural partnership, MilliporeSigma contributed 300 custom-made lab coats for pregnant researchers to KOFWST.
About the Life Science business of Merck KGaA, Darmstadt, Germany
The Life Science business of Merck KGaA, Darmstadt, Germany, which operates as MilliporeSigma in the U.S. and Canada, has more than 23,000 employees and 59 manufacturing sites worldwide, with a portfolio of more than 300,000 products focused on scientific discovery, biomanufacturing and testing services. Merck KGaA, Darmstadt, Germany, a leading science and technology company, operates across healthcare, life science and electronics.
Around 58,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From advancing gene-editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2020, Merck KGaA, Darmstadt, Germany generated sales of € 17.5 billion in 66 countries.
The company holds the global rights to the name and trademark “Merck” internationally. The only exceptions are the United States and Canada, where the business sectors of Merck KGaA, Darmstadt, Germany operate as EMD Serono in healthcare, MilliporeSigma in life science, and EMD Electronics. Since its founding 1668, scientific exploration and responsible entrepreneurship have been key to the company’s technological and scientific advances. To this day, the founding family remains the majority owner of the publicly listed company. For more information about Merck KGaA, Darmstadt, Germany, visit www.emdgroup.com.
All Merck KGaA, Darmstadt, Germany news releases are distributed by email at the same time they become available on the EMD Group website. In case you are a resident of the U.S. or Canada please go to www.emdgroup.com/subscribe to register again for your online subscription of this service as our newly introduced geo-targeting requires new links in the email. You may later change your selection or discontinue this service.
To continue reading please sign in or create an account.Don't Have An Account?